• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | executiveoffice@fsahq.org

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2026 Annual Meeting
      • Exhibitors and Sponsors
    • Call For Abstracts
    • 2025 Annual Meeting Recap
    • Past Posters
      • 2026 FSA Podium and Poster Abstracts
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
      • 2017 FSA Posters
      • 2016 FSA Posters
    • Past Meetings
      • 2024 Annual Meeting Recap
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
    • FSAPAC Donors for 2026
    • PAC Board Resources
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)
  • Login

2026 FSA Podium and Poster Abstracts

All Abstracts Podium Digital Poster Poster

← Back to All Abstracts

P035: HEMODYNAMIC INSTABILITY DURING HISTOTRIPSY
Sofia Cartaya, MD; Kevin Bennett, MD; Cameron Howard, MD; Benjamin Houseman, MD
Memorial Healthcare System

Introduction: Histotripsy is a form of non-thermal tissue ablation that utilizes high-intensity ultrasound to liquefy solid tumors through cavitation (Figure 1). These liquefied masses are later cleared by the immune system. [1] Histotripsy is very precise in targeting lesions, but there is a theoretical potential to impact the heart when lesions are adjacent to the cardiac surface. [2] Here we describe a case of profound hypotension and bradycardia during histotripsy ablation of a segment IVa hepatic metastasis in a 79-year-old man with underlying rhythm abnormalities.

Case Report: A 79-year-old male patient with a history of significant for tachy-brady syndrome on propafenone, hypertension on amlodipine, atrial fibrillation, and metastatic lung cancer to the liver and bone presented for histotripsy of liver metastasis. His preoperative PET CT scan revealed a 1.7-cm lesion in the left liver segment IVa (Figure 2), a 1.5-cm lesion in liver segment VIII, and a 1.9-cm lesion in liver segment VI. Baseline laboratory studies were within normal limits. 

General anesthesia was induced and his airway was secured with a 37F left-sided double-lumen endotracheal tube to permit left lung ventilation. Histotripsy was initially targeted to the 1.7 cm segment IVa lesion. During initial targeting, the patient became hypotensive and bradycardic. Given his underlying conduction disease, ablation of this lesion was aborted. Histotripsy was subsequently performed on lesions in segments VIII and VI without further hemodynamic compromise.

Discussion / Conclusion: Histotripsy permits management of hepatic lesions that were previously considered inoperable and carries fewer risks than hepatectomy. While this procedure has a strong record of safety, risks associated with general anesthesia and lung isolation remain.

This case describes hypotension and bradycardia during histotripsy of a lesion in hepatic segment IVa, which is in close proximity to the heart (Figure 2). To our knowledge, no cases of histotripsy-induced arrhythmia have been reported. While it is possible that histotripsy for this lesion did impact the adjacent cardiac tissue, we feel that it is unlikely given the precision of this technique. We suspect that the patient’s underlying cardiac conduction disease may have contributed to the observed bradycardia. [3] Clinicians should consider augmented monitoring, anticipate need for hemodynamic support, and be willing to discontinue the procedure when challenges arise.  

We note that focused ultrasound is gaining traction for both modulation of conduction in cardiac arrhythmias and deliberate tissue destruction of infarcted myocardium. [3] 

References

[1] doi: 10.1080/02656736.2021.1905189. 

[2] doi: 10.1109/TUFFC.2012.2506

[3] doi: 10.1080/17434440.2016.1217772. 

[4] https://www.prnewswire.com/news-releases/histosonics-announces-published-results-of-phase-i-liver-tumor-trial-301626658.html

[5] https://clinicalpub.com/segmentoriented-anatomic-liver-resections-indications-and-outcomes/

← Back to All Abstracts

Copyright © 2026 · Florida Society of Anesthesiologists · All Rights Reserved